445 related articles for article (PubMed ID: 32661125)
1. Vaccination with Secreted Aspartyl Proteinase 2 Protein from
Shukla M; Rohatgi S
Infect Immun; 2020 Sep; 88(10):. PubMed ID: 32661125
[TBL] [Abstract][Full Text] [Related]
2. Hybrid phage displaying SLAQVKYTSASSI induces protection against Candida albicans challenge in BALB/c mice.
Wang Y; Su Q; Dong S; Shi H; Gao X; Wang L
Hum Vaccin Immunother; 2014; 10(4):1057-63. PubMed ID: 24448202
[TBL] [Abstract][Full Text] [Related]
3. Protection against systemic candidiasis in mice immunized with secreted aspartic proteinase 2.
Vilanova M; Teixeira L; Caramalho I; Torrado E; Marques A; Madureira P; Ribeiro A; Ferreira P; Gama M; Demengeot J
Immunology; 2004 Mar; 111(3):334-42. PubMed ID: 15009435
[TBL] [Abstract][Full Text] [Related]
4. A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine.
Sandini S; La Valle R; Deaglio S; Malavasi F; Cassone A; De Bernardis F
FEMS Immunol Med Microbiol; 2011 Jul; 62(2):215-24. PubMed ID: 21535228
[TBL] [Abstract][Full Text] [Related]
5. Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice.
Li Wq; Hu Xc; Zhang X; Ge Y; Zhao S; Hu Y; Ashman RB
Vaccine; 2011 Jul; 29(33):5526-33. PubMed ID: 21645574
[TBL] [Abstract][Full Text] [Related]
6. Expression and Purification along with Evaluation of Serological Response and Diagnostic Potential of Recombinant Sap2 Protein from
Shukla M; Chandley P; Kaur H; Ghosh AK; Rudramurthy SM; Rohatgi S
J Fungi (Basel); 2021 Nov; 7(12):. PubMed ID: 34946982
[TBL] [Abstract][Full Text] [Related]
7. Genetically Engineered Virus Nanofibers as an Efficient Vaccine for Preventing Fungal Infection.
Huai Y; Dong S; Zhu Y; Li X; Cao B; Gao X; Yang M; Wang L; Mao C
Adv Healthc Mater; 2016 Apr; 5(7):786-94. PubMed ID: 26890982
[TBL] [Abstract][Full Text] [Related]
8. Nasal vaccination induces the ability to eliminate Candida colonization without influencing the pre-existing antigen-specific IgE Abs: a possibility for the control of Candida-related atopic dermatitis.
Suenobu N; Kweon MN; Kiyono H
Vaccine; 2002 Jul; 20(23-24):2972-80. PubMed ID: 12126910
[TBL] [Abstract][Full Text] [Related]
9. The anti-Candida albicans vaccine composed of the recombinant N terminus of Als1p reduces fungal burden and improves survival in both immunocompetent and immunocompromised mice.
Spellberg BJ; Ibrahim AS; Avenissian V; Filler SG; Myers CL; Fu Y; Edwards JE
Infect Immun; 2005 Sep; 73(9):6191-3. PubMed ID: 16113347
[TBL] [Abstract][Full Text] [Related]
10. Serum and saliva antibodies do not inhibit Candida albicans Sap2 proteinase activity using a BSA hydrolysis assay.
Naglik JR; Scott J; Rahman D; Mistry M; Challacombe SJ
Med Mycol; 2005 Feb; 43(1):73-7. PubMed ID: 15712610
[TBL] [Abstract][Full Text] [Related]
11. [Immunoprotection by Sap2 and dendritic cells against systemic Candida albicans infection in mice].
Xu M; Liu J
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jun; 34(7):1030-4. PubMed ID: 25057078
[TBL] [Abstract][Full Text] [Related]
12. Systemic and mucosal immunization with Candida albicans hsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis.
Raska M; Belakova J; Horynova M; Krupka M; Novotny J; Sebestova M; Weigl E
Med Mycol; 2008 Aug; 46(5):411-20. PubMed ID: 18608941
[TBL] [Abstract][Full Text] [Related]
13. Protective antigens and mechanisms of anti-Candida immunity.
Antonio C
Nihon Ishinkin Gakkai Zasshi; 2000; 41(4):219. PubMed ID: 11064318
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Mdh1 protein as an antigenic candidate for a vaccine against candidiasis.
Shibasaki S; Aoki W; Nomura T; Karasaki M; Sewaki T; Ueda M
Biocontrol Sci; 2014; 19(1):51-5. PubMed ID: 24670619
[TBL] [Abstract][Full Text] [Related]
15. NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune response.
Ibrahim AS; Luo G; Gebremariam T; Lee H; Schmidt CS; Hennessey JP; French SW; Yeaman MR; Filler SG; Edwards JE
Vaccine; 2013 Nov; 31(47):5549-56. PubMed ID: 24063977
[TBL] [Abstract][Full Text] [Related]
16. Moonlighting proteins induce protection in a mouse model against Candida species.
Medrano-Díaz CL; Vega-González A; Ruiz-Baca E; Moreno A; Cuéllar-Cruz M
Microb Pathog; 2018 Nov; 124():21-29. PubMed ID: 30118801
[TBL] [Abstract][Full Text] [Related]
17. A virosomal vaccine against candidal vaginitis: immunogenicity, efficacy and safety profile in animal models.
De Bernardis F; Amacker M; Arancia S; Sandini S; Gremion C; Zurbriggen R; Moser C; Cassone A
Vaccine; 2012 Jun; 30(30):4490-8. PubMed ID: 22561143
[TBL] [Abstract][Full Text] [Related]
18. Novel nanoscale bacteriophage-based single-domain antibodies for the therapy of systemic infection caused by Candida albicans.
Dong S; Shi H; Cao D; Wang Y; Zhang X; Li Y; Gao X; Wang L
Sci Rep; 2016 Aug; 6():32256. PubMed ID: 27558409
[TBL] [Abstract][Full Text] [Related]
19. Epitope mapping Candida albicans proteinase (SAP 2).
Ghadjari A; Matthews RC; Burnie JP
FEMS Immunol Med Microbiol; 1997 Oct; 19(2):115-23. PubMed ID: 9395056
[TBL] [Abstract][Full Text] [Related]
20. The use of hybrid phage displaying antigen epitope and recombinant protein in the diagnosis of systemic Candida albicans infection in rabbits and cancer patients.
Quanping S; Yanyan H; Yicun W; Zhigang J; Yuling G; Li W
Diagn Microbiol Infect Dis; 2010 Dec; 68(4):382-9. PubMed ID: 20884151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
